1) angiogenesis inhibitor
新生血管抑制剂
1.
Synthesis and biological evaluation of 7-hydroxy-3-(4-hydroxyphenyl)-6-methoxy-4H-chromen-4-one as angiogenesis inhibitor;
方法以异香兰素为起始原料,经过插氧、水解、酰化和环合四步反应合成目标化合物;以新生血管抑制剂2-甲氧基雌二醇为阳性对照,采用人脐静脉内皮细胞(human umbilical vein endothelial cells,HUVECs)筛药模型和子宫内膜基质细胞(endometrial stromal cells,ESCs)模型分别测定该化合物的新生血管抑制活性和细胞毒性。
2) neovascularization inhibitor
新生血管抑制剂
1.
Research progress of choroid neovascularization inhibitors;
脉络膜新生血管抑制剂的研究进展
2.
As the mechanism of CNV further develops in recent years,more and more researches about ROP have been undergone on neovascularization inhibitor.
近年来随着新生血管研究的深入,新生血管抑制剂用于预防及治疗ROP的研究也越来越多,本文拟对近年来有关ROP上述研究进展作一综述。
3) tumor angiogenensis inhibitors(TAIs)
新生血管生成抑制剂
1.
Two pharmacological strategies invovled in this field were tumor angiogenensis inhibitors(TAIs)and vascular targeting agents(VTAs).
抗肿瘤血管的治疗策略分为肿瘤新生血管生成抑制剂(tumor angiogenesis inhibitor,TAI)和肿瘤血管靶向药物(vasculartar getingagents,VTAs)两方面的研究。
4) angiogenesis inhibitors
血管生成抑制剂
1.
Advances in research on screening models of tumor angiogenesis inhibitors;
肿瘤血管生成抑制剂筛选模型的研究进展
2.
New agents of traditional cytotoxity, targeted agents such as protein tyrosine kinase inhibitors, tumor angiogenesis inhibitors and gene therapy are focused in this paper.
文章综述近几年来抗肿瘤药物新进展,包括新的细胞毒性抗肿瘤药,针对关键靶点的新型抗肿瘤药如酪氨酸激酶抑制剂、血管生成抑制剂以及基因疗法等。
3.
Feasibility for inhibiting tumor metastasis with Chinese herbal medicines as angiogenesis inhibitors;
抑制肿瘤血管生成是控制肿瘤生长和转移的重要途径之一,以肿瘤血管形成为靶点的血管生成抑制剂研究已成为当前肿瘤基础理论和临床研究的热点。
5) angiogenesis inhibitor
血管生成抑制剂
1.
Study of angiogenesis inhibitor NM-3 on the growth of human gastric cancer;
血管生成抑制剂NM-3抑制胃癌生长机制研究
2.
Objective To study the effect of angiogenesis inhibitor and its combine with chemical drug in suppressing the growth of adenoid cystic carcinoma (ACC).
目的 探讨单独使用血管生成抑制剂及其与化疗药联合对腺样囊性癌裸鼠移植瘤生长的影响。
3.
Objective:To investigate the effects of tumor angiogenesis inhibitor endostatin on healing of gastrointestinal anastomoses in the dog.
目的 :研究肿瘤血管生成抑制剂内皮抑素 (endostatin)对胃癌术后胃肠吻合口愈合的影响。
补充资料：血管紧张素转换酶抑制剂
血管紧张素转换酶抑制剂
converting enzyme inhibitor of angiotensin
能够抑制血管紧张素转换酶的活性、使血管紧张素Ⅰ不能转换成血管紧张素Ⅱ的物质，如替普罗肽(又称SQ20881）及卡托普利(又称SQ14225）。用于肾血管性高血压及高血压危象。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条